{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:33Z","timestamp":1781089113004,"version":"3.54.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u00e6\u00b5\u2122\u00e6\u00b1\u0178\u00e7\u0153\u0081\u00e5\u2026\u00ac\u00e7\u203a\u0160\u00e6\u0160\u20ac\u00e6\u0153\u00af\u00e7 \u201d\u00e7\u00a9\u00b6\u00e7 \u201d\u00e7\u00a9\u00b6\u00e8\u00ae\u00a1\u00e5\u02c6\u2019","award":["LGF21H090001"],"award-info":[{"award-number":["LGF21H090001"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) is a common hematologic malignancy characterized by widespread systemic involvement. Radiation therapy is the 1st-line treatment for MM patients with brain metastases in clinical practice, whereas surgical intervention is only sporadically reported in special cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A MM patient receiving conventional chemotherapy presented with progressive motor dysfunction of the right limb. Imaging examinations revealed a space-occupying lesion in the left parietal lobe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Following multidisciplinary consultation involving hematology and neurosurgery departments, the patient was diagnosed with central nervous system multiple myeloma (CNS-MM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Prompt symptomatic treatments, including intracranial pressure reduction and antiepileptic therapy, were initiated, but the patient\u2019s muscle strength continued to deteriorate to grade II. A left parietal lobe brain tumor resection was then performed after comprehensive evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>\n                      Postoperatively, the patient\u2019s muscle strength recovered rapidly, and no tumor recurrence was noted during follow-up. However, the patient eventually died of uncontrolled pulmonary\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>CNS-MM is associated with a poor prognosis, and the current treatment strategies remain suboptimal. Surgical intervention may be a viable option for patients with rapidly progressive CNS-MM. This case comprehensively analyzes the potential benefits of surgical treatment for specific CNS-MM patients, based on existing treatment protocols and relevant case reports.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047258","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:26Z","timestamp":1769191346000},"page":"e47258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking surgical intervention in the multidisciplinary comprehensive management of craniocerebral metastasis in multiple myeloma"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8717-0515","authenticated-orcid":false,"given":"Junjie","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Huzhou First People's Hospital, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huzhou First People's Hospital, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huzhou First People's Hospital, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Huzhou First People's Hospital, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41408-021-00527-y","article-title":"Extramedullary disease in multiple myeloma.","volume":"11","author":"Bansal","year":"2021","journal-title":"Blood Cancer J"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review.","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/ijc.IJC_560_20","article-title":"Central nervous system involvement in multiple myeloma: experience from a tertiary cancer center and review of literature.","volume":"62","author":"Jain","year":"2023","journal-title":"Indian J Cancer"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clml.2016.08.010","article-title":"Myelomatous involvement of the central nervous system.","volume":"16","author":"Paludo","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jocn.2018.01.054","article-title":"Intracranial hemorrhage as initial manifestation of plasma cell myeloma: a case report.","volume":"50","author":"Hobbs","year":"2018","journal-title":"J Clin Neurosci"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.17925","article-title":"Identification of patients at high risk of secondary extramedullary multiple myeloma development.","volume":"196","author":"Stork","year":"2022","journal-title":"Br J Haematol"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.24351","article-title":"Central nervous system involvement by multiple myeloma: a multi-institutional retrospective study of 172 patients in daily clinical practice.","volume":"91","author":"Jurczyszyn","year":"2016","journal-title":"Am J Hematol"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.leukres.2008.09.018","article-title":"Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients.","volume":"33","author":"Oliveira","year":"2009","journal-title":"Leuk Res"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1600-0609.2003.00022.x","article-title":"Can thalidomide be effective to treat plasma cell leptomeningeal infiltration.","volume":"70","author":"Vicari","year":"2003","journal-title":"Eur J Haematol"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/ejh.12247","article-title":"Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement.","volume":"92","author":"Nahi","year":"2014","journal-title":"Eur J Haematol"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"101465","DOI":"10.1016\/j.tranon.2022.101465","article-title":"Advances in the treatment of extramedullary disease in multiple myeloma.","volume":"22","author":"Li","year":"2022","journal-title":"Transl Oncol"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jcpt.13054","article-title":"Successful treatment with pomalidomide and intrathecal injections for central nervous system plasmacytoma in a patient under haemodialysis.","volume":"45","author":"Oka","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00277-015-2484-y","article-title":"Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.","volume":"94","author":"Katodritou","year":"2015","journal-title":"Ann Hematol"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871524914999140818111514","article-title":"Novel agents in CNS myeloma treatment.","volume":"14","author":"Gozzetti","year":"2014","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2298\/VSP1202209M","article-title":"Multiple myeloma invasion of the central nervous system.","volume":"69","author":"Marjanovi\u0107","year":"2012","journal-title":"Vojnosanit Pregl"},{"key":"R17-20260610","first-page":"1571","article-title":"Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.","volume":"47","author":"Greig","year":"1987","journal-title":"Cancer Res"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"552429","DOI":"10.3389\/fimmu.2021.552429","article-title":"Case report: reversible neurotoxicity and a clinical response induced by BCMA-directed chimeric antigen receptor T cells against multiple myeloma with central nervous system involvement.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1182\/bloodadvances.2024014345","article-title":"BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement.","volume":"9","author":"Gaballa","year":"2025","journal-title":"Blood Adv"},{"key":"R20-20260610","first-page":"3065","article-title":"Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma.","volume":"110","author":"Portuguese","year":"2025","journal-title":"Haematologica"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1200\/JCO.23.00512","article-title":"Chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma: moving into the future.","volume":"41","author":"Holstein","year":"2023","journal-title":"J Clin Oncol"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"1276295","DOI":"10.3389\/fimmu.2023.1276295","article-title":"Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case.","volume":"14","author":"Mutlu","year":"2023","journal-title":"Front Immunol"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clineuro.2009.11.003","article-title":"Intracranial plasmacytoma with apoplectic presentation and spontaneous intracerebral hemorrhage: case report and review of the literature.","volume":"112","author":"Crowley","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"55","DOI":"10.25259\/SNI_693_2020","article-title":"Intracranial plasmacytoma arising from dura mater secondary to multiple myeloma and presenting with sudden lethal intracerebral hemorrhage: a case report and literature review.","volume":"12","author":"Onodera","year":"2021","journal-title":"Surg Neurol Int"},{"key":"R25-20260610","first-page":"e8357","article-title":"Multiple myeloma relapse as intracranial plasmacytoma: a rare presentation.","volume":"12","author":"Prakash","year":"2020","journal-title":"Cureus"},{"key":"R26-20260610","doi-asserted-by":"crossref","first-page":"102730","DOI":"10.1016\/j.bas.2023.102730","article-title":"Cerebral tumor with hemi-dural enhancement as unique presentation of multiple myeloma: a case report.","volume":"4","author":"van Lanen","year":"2023","journal-title":"Brain Spine"},{"key":"R27-20260610","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s002340050325","article-title":"Intracranial plasmacytoma: a case report.","volume":"38","author":"M\u00e4ntyl\u00e4","year":"1996","journal-title":"Neuroradiology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:51Z","timestamp":1781085771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047258","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-02-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}